Sangon Biotech

About Sangon Biotech

Established in 2003 in Shanghai, China, Sangon Biotech has become a comprehensive provider of life science research tools and services. The company initially focused on oligo synthesis before expanding its portfolio to serve as a one-stop shop for the life sciences sector.

The firm operates in the biotechnology and pharmaceuticals industries, catering to a broad client base that includes over 7,000 academic institutions and more than 40,000 biotech, biopharmaceutical, and in vitro diagnostic (IVD) companies, primarily in China but with exports to the United States, Canada, and Europe. Sangon Biotech's business model is centered on being an original manufacturer, which allows it to offer a wide array of products and services at competitive prices. The company generates revenue through the sale of its extensive product line and service offerings.

Sangon Biotech's offerings are divided into four main categories: DNA synthesis, R&D reagents and consumables, genetic sequencing, and protein and antibody-related products and services. This includes a catalog of over 30,000 life science products such as molecular biology kits, biochemicals, synthetic genes, and peptides. Their service portfolio is extensive, featuring DNA and Next-Generation Sequencing (NGS), gene and peptide synthesis, protein expression, and antibody production. The company emphasizes its technical capabilities, such as Sanger DNA sequencing with high success rates and NGS on multiple platforms like Illumina and Ion Torrent.

Significant milestones for Sangon Biotech include substantial funding rounds to fuel its growth. The company has raised a total of $300 million over two rounds. A Series A round in August 2010 brought in $10 million, and a much larger Series B round in April 2023 secured $290 million. This recent strategic financing was led by prominent investors including Greenwoods Investments, GL Capital, and Novo Holdings, and is intended to expand the company's service portfolio, accelerate R&D, and support digitalization and geographical expansion.